Display options
Share it on

Evol Med Public Health. 2015 Jan 20;2015(1):21-31. doi: 10.1093/emph/eov002.

Illness in breastfeeding infants relates to concentration of lactoferrin and secretory Immunoglobulin A in mother's milk.

Evolution, medicine, and public health

Alicia A Breakey, Katie Hinde, Claudia R Valeggia, Allison Sinofsky, Peter T Ellison

Affiliations

  1. Department of Human Evolutionary Biology, Harvard University, Cambridge MA 02138, USA, Department of Anthropology, Yale University, 10 Sachem St., New Haven CT 06511, USA [email protected].
  2. Department of Human Evolutionary Biology, Harvard University, Cambridge MA 02138, USA, Department of Anthropology, Yale University, 10 Sachem St., New Haven CT 06511, USA.

PMID: 25608691 PMCID: PMC4334701 DOI: 10.1093/emph/eov002

Abstract

BACKGROUND AND OBJECTIVES: This study aims to better understand the relationship between immune compounds in human milk and infant health. We hypothesized that the concentration of immune compounds in milk would relate to infant illness symptoms according to two possible theoretical paradigms. In the 'protective' paradigm, high concentrations of immune compounds prevent infant illness. The converse, the 'responsive' framework, posits that concentrations of immune compounds are elevated in response to infection.

METHODOLOGY: Milk samples (n = 110) and illness data were collected among the Toba of Argentina from 30 mother-infant dyads. Samples were assayed for two immune proteins, lactoferrin and secretory immunoglobulin A (sIgA). Generalized estimating equations were used to assess the relationship between immune composition of milk and symptoms of illness in infants.

RESULTS: Lactoferrin was positively associated with symptoms of illness in infants (odds ratios >1), both in the month preceding the sample collection and the subsequent month. sIgA was negatively associated with symptoms (odds ratios <1) in the preceding and subsequent months, an association which was particularly strong for gastrointestinal symptoms.

CONCLUSIONS AND IMPLICATIONS: The two compounds investigated in our study had opposite relationships with symptoms of illness; the positive relationship between lactoferrin and illness lends support to our 'responsive' paradigm, and the negative relationship between sIgA and symptoms of illness was consistent with our 'protective' framework. That elevated lactoferrin is restricted to periods of illness suggests that there may be a cost to mother or infant associated with persistently elevated lactoferrin that is not incurred with elevated sIgA.

© The Author(s) 2015. Published by Oxford University Press on behalf of the Foundation for Evolution, Medicine, and Public Health.

Keywords: biology; infant illness; lactation; lactoferrin; life history; milk immunofactors; sIgA

References

  1. J Pediatr Gastroenterol Nutr. 2007 Feb;44(2):245-51 - PubMed
  2. Adv Exp Med Biol. 1998;443:141-53 - PubMed
  3. Br Med J. 1972 Jan 8;1(5792):69-75 - PubMed
  4. Nutr Res Rev. 1996 Jan;9(1):89-110 - PubMed
  5. J Biosoc Sci. 2004 Sep;36(5):573-95 - PubMed
  6. Biometals. 2004 Jun;17(3):225-9 - PubMed
  7. Clin Transl Immunology. 2013 Apr 12;2(4):e3 - PubMed
  8. Am J Clin Nutr. 2002 Oct;76(4):858-64 - PubMed
  9. Arch Argent Pediatr. 2014 Jun;112(3):254-7 - PubMed
  10. Am J Clin Nutr. 1995 Sep;62(3):559-63 - PubMed
  11. Trends Immunol. 2001 Apr;22(4):205-11 - PubMed
  12. J Pediatr. 1990 May;116(5):707-13 - PubMed
  13. Pediatrics. 1994 Jan;93(1):28-31 - PubMed
  14. Cell Mol Life Sci. 2005 Nov;62(22):2588-98 - PubMed
  15. Vaccine. 2003 Jul 28;21(24):3382-8 - PubMed
  16. Proc Nutr Soc. 1995 Jul;54(2):391-400 - PubMed
  17. Am J Epidemiol. 1998 May 1;147(9):863-70 - PubMed
  18. J Hum Lact. 2013 May;29(2):171-82 - PubMed
  19. Am J Hum Biol. 2013 Jan-Feb;25(1):1-11 - PubMed
  20. Med Microbiol Immunol. 1993 Mar;182(1):25-35 - PubMed
  21. APMIS. 1999 Nov;107(11):971-81 - PubMed
  22. Early Hum Dev. 1997 Oct 29;49 Suppl:S7-28 - PubMed
  23. J Mammary Gland Biol Neoplasia. 2012 Jun;17(2):167-88 - PubMed
  24. Biol Neonate. 1995;67(5):330-9 - PubMed
  25. Pediatrics. 2001 Oct;108(4):E67 - PubMed
  26. BMC Public Health. 2011 Apr 13;11 Suppl 3:S15 - PubMed
  27. J Nutr. 2005 Jan;135(1):1-4 - PubMed

Publication Types

Grant support